As heterogeneity also exists in cancer stem cells [31], we wondered whether different subpopulations of pancreatic cancer stem cells exhibit distinct inhibitory immune checkpoints except for CEACAM5. The gene discussed is CEACAM5; the disease is pancreatic neoplasm.